Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Primary Hormonal Therapy for Ductal Carcinoma in Situ: Exploration of a Novel Approach to the Clinical Management of Noninvasive Breast Cancer

NCT00290745 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT00290745
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00290745 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Primary Hormonal Therapy for Ductal Carcinoma in Situ: Exploration of a Novel Approach to the Clinical Management of Noninvasive Breast Cancer
Lead sponsor
University of California, San Francisco
Phase
Phase 1/2
Overall status
Completed
Start date
February 19, 2002
Completion date
June 30, 2011
Enrollment
79 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer